Sermorelin

Category
peptide
Half-Life (t½)
SC: 4m
Formula
C149H246N44O42S
Molecular Weight
3357.9 g/mol
PubChem CID
16132413
Aliases
GHRH(1-29), GRF(1-29)NH₂, Geref

Pharmacological Mechanism

Truncated 29-residue N-terminal fragment of native GHRH — retains full GH-releasing activity. Binds GHRH-R on somatotrophs → cAMP rise → GH release. Preserves physiologic negative-feedback loop (unlike direct HGH injection) so overtreatment risk is lower. Very short plasma t½ (~11 min) — divided or evening dosing.

Half-Life & Elimination Curve (SC: 4m)

100%50%25%12.5%0%0h0×t½4m1×t½8m2×t½13m3×t½17m4×t½21m5×t½0×t½ (0h): 100% remaining1×t½ (4m): 50% remaining2×t½ (8m): 25% remaining3×t½ (13m): 12.5% remaining4×t½ (17m): 6.3% remaining5×t½ (21m): 3.1% remaining
Plasma (SC)t½ Decay (4m)
  • 0×t½0h100%
  • 1×t½4m50%
  • 2×t½8m25%
  • 3×t½13m12.5%
  • 4×t½17m6.3%
  • 5×t½21m3.1%
Elimination t½4m (SC)
Rate Constant (ke)9.9 h⁻¹
Time to Peak (Tmax)10m
Clearance (CL)69.3 L/h
97% Washout (5×t½)21m

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References